| Literature DB >> 26880965 |
Polina I Bobyleva1, Elena R Andreeva1, Aleksandra N Gornostaeva1, Ludmila B Buravkova1.
Abstract
Human adipose tissue-stromal derived cells (ASCs) are considered a perspective tool for regenerative medicine. Depending on the application mode ASC/allogeneic immune cell interaction can occur in the systemic circulation under plenty high concentrations of O2 and in target tissues at lower O2 levels. Here we examined the effects of allogeneic PHA-stimulated peripheral blood mononuclear cells (PBMCs) on ASCs under ambient (20%) oxygen and "physiological" hypoxia (5% O2). As revealed with microarray analysis ASCs under 20% O2 were more affected by activated PBMCs, which was manifested in differential expression of more than 300 genes, whereas under 5% O2 only 140 genes were changed. Altered gene pattern was only partly overlapped at different O2 conditions. Under O2 ASCs retained their proliferative and differentiative capacities, mesenchymal phenotype, and intracellular organelle' state. ASCs were proinflammatory activated on transcription level that was confirmed by their ability to suppress activation and proliferation of mitogen-stimulated PBMCs. ASC/PBMCs interaction resulted in anti-inflammatory shift of paracrine mediators in conditioning medium with significant increase of immunosuppressive LIF level. Our data indicated that under both ambient and tissue-related O2 ASCs possessed immunosuppressive potential and maintained functional activity. Under "physiological" hypoxia ASCs were less susceptible to "priming" by allogeneic mitogen-activated PBMCs.Entities:
Year: 2016 PMID: 26880965 PMCID: PMC4736565 DOI: 10.1155/2016/4726267
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Figure 1ASC morphology in monoculture and after transwell coculture with PHA-stimulated PBMCs under 20% and 5% O2. Phase contrast: bar 100 μm.
Figure 2ASC immunophenotype after monoculture and transwell coculture with PHA-stimulated PBMCs under 20% and 5% O2. (a) Representative histograms of ASC surface marker expression. The white filled histograms indicate the positively stained cells while the grey filled histograms indicate the isotype-matched antibody controls. (b) CD90 mean fluorescence intensity (MFI) on cocultured ASCs versus ASCs in monoculture. (c) The proportion of CD54-positive ASCs in monoculture and transwell coculture with PBMCs. (d) CD54 MFI on cocultured ASCs versus ASCs in monoculture. Significant difference between monoculture and coculture at 20% O2 (p < 0.01). #Significant difference between monoculture and coculture at 5% O2 (p < 0.01).
Figure 3Cellular organelle state and ROS level in ASCs after coculture with PHA-stimulated PBMCs versus ASCs in monoculture. Transmembrane mitochondrial potential (a), lysosome activity (b), endoplasmic reticulum activity (c), and ROS production (d). Significant difference between monocultured and cocultured ASCs at 20% O2 (p < 0.01). #Significant difference between monocultured and cocultured ASCs at 5% O2 (p < 0.01).
Figure 4ASC functions after paracrine interaction with PHA-stimulated PBMCs. (a) ASC viability: percentage of viable, apoptotic, and necrotic cells in monoculture and after coculture during 72 h at 20% and 5% O2. (b) ASC proliferation: the change in cell number in monoculture and after coculture during 72 h at 20% and 5% O2. (c) Matrix mineralization of ASCs at 20% (1) and 5% O2 (2), alizarin red staining: bar 200 μm. (d) Osteodifferentiation: matrix mineralization in monocultured and cocultured ASCs. Significant difference between ASC under 20% and 5% O2 in monoculture. #Significant difference between ASC under 20% and 5% O2 in coculture.
Activation and proliferation rate of PBMCs after coculture with ASCs.
| 20% О2 | 5% О2 | |
|---|---|---|
| Activation (CD3+/HLA-DR+) | 40.6 ± 6.5 | 48.6 ± 5.3 |
| Proliferation rate | 22 ± 5 | 15 ± 2 |
Data are presented as a percentage of changes, when effects in PHA-stimulated PBMC monoculture were considered as 100%. Mean ± SD of 5 independent experiments. Significant difference from PBMC monoculture (p < 0.05).
Figure 5Concentration of soluble mediators in conditioned medium after 72 hrs of culture. Significant difference between ASC under 20% and 5% O2 in monoculture. #Significant difference between ASC under 20% and 5% O2 in coculture.
Figure 6Characterisation of differential gene expression in ASCs after paracrine interaction with PHA-stimulated allogeneic PBMCs. (a) Venn diagram, showing the number of ASC genes commonly or differentially expressed at 20% and 5% O2. (b) The number of differentially expressed genes in Gene Ontology (GO) groups (biological function).
Summary of most important differentially expressed ASC genes after paracrine interaction with PHA-stimulated PBMCs under different O2 concentrations, as determined by microarray analysis.
| Gene | Product | ASC + PBMCs versus ASCs, fold change | |
|---|---|---|---|
| 20% О2 | 5% О2 | ||
| Proinflammatory activation | |||
|
| TRAF3 interacting protein 2 | 4.6 | 9.3 |
|
| Interleukin-1 receptor-associated kinase 3 | 6.3 | 6.2 |
|
| Interleukin-1 receptor-associated kinase 2 | 5.7 | 6.5 |
|
| Tumor necrosis factor, alpha-induced protein 3 | 5.1 | 5.2 |
|
| Interferon-induced protein 44 | 5.8 | 6.8 |
|
| Interferon, alpha-inducible protein 6, transcript variant 2 | 11.1 | 10.6 |
|
| Interferon, alpha-inducible protein 6, transcript variant 3 | 4.4 | 6.3 |
|
| ISG15 ubiquitin-like modifier | 4.3 | 4.6 |
|
| Guanylate binding protein 2, interferon-inducible | 3.7 | 5.2 |
|
| Interferon, alpha-inducible protein 27 | 4.3 | 5.4 |
|
| Major histocompatibility complex, class I, H | 2.9 | 3.8 |
|
| Collectin subfamily member 12 | 5.4 | 7.3 |
|
| |||
| Paracrine regulation | |||
|
| Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 46.3 | 1 |
|
| Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 3.0 | 3.8 |
|
| Chemokine (C-X-C motif) ligand 5 (CXCL5) | 328.3 | 1 |
|
| Chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 200.7 | 1 |
|
| Chemokine (C-C motif) ligand 2 (monocyte chemotactic protein 1) | 11.6 | 52.4 |
|
| Chemokine (C-C motif) ligand 5 (RANTES) | 5.6 | 7.4 |
|
| Interleukin 11 | 14.2 | 16.8 |
|
| Interleukin 1, beta | 28.7 | 95.5 |
|
| Interleukin 8 | 81.4 | 28.0 |
|
| |||
| Immunosuppression | |||
|
| Major histocompatibility complex, class I, B | 4.6 | 5.1 |
|
| Major histocompatibility complex, class I, F | 2.7 | 1 |
|
| Major histocompatibility complex, class I, H | 2.9 | 3.8 |
|
| Prostaglandin I2 (prostacyclin) synthase | 0.13 | 2.0 |
|
| Transforming growth factor, beta-induced | 0.33 | 33.2 |
|
| Leukemia inhibitory factor (cholinergic differentiation factor) | 3.0 | 7.4 |
|
| Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 5.3 | 3.7 |
|
| |||
| Extracellular matrix | |||
|
| Collagen, type XII, alpha 1 | 0.2 | 1 |
|
| Collagen, type VI, alpha 2 | 3.2 | 1 |
|
| Collagen, type VII, alpha 1 | 6.5 | 7.3 |
|
| Metallopeptidase 1 (interstitial collagenase) | 18.9 | 9.2 |
|
| Matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 266.6 | 317.6 |
|
| |||
| Migration | |||
|
| Podocan | 0.1 | 0.1 |
|
| Hyaluronan synthase 2 | 12.8 | 8.1 |
|
| Slit homolog 2 | 4.8 | 3.9 |
|
| Sphingosine kinase 1 | 2.5 | 1 |
|
| |||
| Cell-matrix interaction | |||
|
| Integrin, alpha 11 | 0.2 | 1 |
|
| Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 4.9 | 1 |
|
| Integrin, beta 5 | 0.3 | 1 |
|
| Podocalyxin-like protein | 0.1 | 1 |
|
| Podoplanin | 4.6 | 4.2 |
|
| Milk fat globule-EGF factor 8 protein (lactadherin) | 0.2 | 1 |
|
| |||
| Proliferation | |||
|
| Cyclin-dependent kinase inhibitor 3 | 9.6 | 1 |
|
| Cyclin B2 | 8.1 | 1 |
|
| Cell division cycle 20 homolog | 6.0 | 17.5 |
|
| Minichromosome maintenance complex component 4 | 14.4 | 7.2 |
|
| Cyclin-dependent kinase inhibitor 2B | 0.1 | 0.1 |
Fold changes are for comparison between ASCs in monoculture and coculture. Positive values indicate higher and negative values indicate lower expression in cocultured ASCs. p < 0.05.